Javier CLEMENTE-CASARES

Nationality Spanish
Year of selection2010
InstitutionUniversity of Calgary
CountryCanada
RiskLife risks

Type of support

Ph.D

Granted amount

120 000 €

Duration

3 years

A nanovaccine for juvenile diabetes

Juvenile diabetes is an autoimmune disease resulting from an attack that destroys pancreatic cells that secrete insulin. Javier Clemente Casares is studying a therapeutic approach that could lead to a nanovaccine for the disease.

To add or modify information on this page, please contact us at the following address: community.research@axa.com